Safety and Efficacy of the GORE® Septal Occluder to Treat Ostium Secundum Atrial Septal Defects

Clinical trial NCT01711983 · COMPLETED

Trial details

NCT number: NCT01711983
Sponsor: W.L.Gore & Associates
Status: COMPLETED
Phase: Not Applicable
Study type: INTERVENTIONAL

Septal Defect, Atrial

Start date: 2012-10-01
Primary completion: 2018-11-26
Enrollment: 400

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.